» Articles » PMID: 8850437

Nutrition and Prostate Cancer

Overview
Specialties Oncology
Public Health
Date 1996 Jan 1
PMID 8850437
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiologic evidence on the relation between nutrition and prostate cancer is reviewed. Little is known about the etiology of prostate cancer, despite its prominence as the leading cancer among men in the United States. Rational mechanisms for dietary influences on prostate carcinogenesis, including effects on production or metabolism of androgenic hormones, have been proposed, but because few suitable animal models have been developed, the laboratory literature on diet and prostate cancer is sparse. Despite strong ecologic data and largely consistent case-control and cohort data on dietary fat and prostate cancer, the role of this nutrient remains unclear. Few studies, to date, have adjusted the results for caloric intake, and no particular fat component has been consistently implicated. A notable finding is a strong positive association with intake of animal products, especially red meats, but this in itself does not specifically implicate fat. Epidemiologic investigations on vitamin A and carotenoids are divided almost equally between studies showing positive and inverse associations. The evidence from these studies for a protective effect of fruits and vegetables on prostate cancer, unlike many other cancer sites, is not convincing. The data on other dietary components that have been examined with regard to prostate cancer etiology (cadmium, zinc, vitamins C and D, beverages, and legumes) are too incomplete at this time to draw any inferences as to their importance. The evidence for anthropometric associations with prostate cancer is weak. Whereas a clear association with obesity has not been shown, a positive relationship to muscle mass, though not yet established conclusively, further suggests the importance of androgens in this cancer.

Citing Articles

Active Holistic Surveillance: The Nutritional Aspect of Delayed Intervention in Prostate Cancer.

Berg C, Habibian D, Katz A, Kosinski K, Corcoran A, Fontes A J Nutr Metab. 2016; 2016:2917065.

PMID: 27274870 PMC: 4871970. DOI: 10.1155/2016/2917065.


Association between dietary inflammatory index and prostate cancer among Italian men.

Shivappa N, Bosetti C, Zucchetto A, Montella M, Serraino D, La Vecchia C Br J Nutr. 2014; 113(2):278-83.

PMID: 25400225 PMC: 4433863. DOI: 10.1017/S0007114514003572.


Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression.

Lloyd J, Masko E, Wu C, Keenan M, Pilla D, Aronson W Prostate Cancer Prostatic Dis. 2013; 16(4):285-91.

PMID: 23877027 PMC: 3830640. DOI: 10.1038/pcan.2013.19.


Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.

Dimitropoulou P, Martin R, Turner E, Lane J, Gilbert R, Davis M Br J Cancer. 2011; 104(5):875-81.

PMID: 21266978 PMC: 3048201. DOI: 10.1038/sj.bjc.6606066.


Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model.

Lloyd J, Antonelli J, Phillips T, Masko E, Thomas J, Poulton S J Urol. 2010; 183(4):1619-24.

PMID: 20172549 PMC: 3766524. DOI: 10.1016/j.juro.2009.12.003.


References
1.
Howell M . Factor analysis of international cancer mortality data and per capita food consumption. Br J Cancer. 1974; 29(4):328-36. PMC: 2009175. DOI: 10.1038/bjc.1974.75. View

2.
Hsing A, McLaughlin J, SCHUMAN L, BJELKE E, Gridley G, Wacholder S . Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990; 50(21):6836-40. View

3.
Ross R, Bernstein L, Lobo R, Shimizu H, Stanczyk F, Pike M . 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992; 339(8798):887-9. DOI: 10.1016/0140-6736(92)90927-u. View

4.
West D, Slattery M, Robison L, French T, Mahoney A . Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991; 2(2):85-94. DOI: 10.1007/BF00053126. View

5.
Nomura A, Heilbrun L, STEMMERMANN G, Judd H . Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res. 1988; 48(12):3515-7. View